552
P. Thakur et al. / Tetrahedron: Asymmetry 23 (2012) 547–553
½
a 2D7
ꢂ
¼ ꢀ138:2 (c 1.3, CHCl3). IR (Neat) 3481, 2926, 1688, 1496,
quickly. After 15 min of stirring, alcohol 9a (250 mg, 0.925 mmol)
1256, 1160, 1040, 701 cmꢀ1 1H NMR (300 MHz, CDCl3): d 7.36–
;
was added as a solution in 10 mL of dichloromethane along with
a small amount of DMAP (10 mg). The cooling bath was removed
and stirring was continued for 6 h. The solution was filtered and
the solvent was removed under reduced pressure. The resulting
oil was purified by column chromatography using (5% ethylacetate
in hexane) to give 17 (402 mg, 90%) as a colourless oil. Rf = 0.4
7.25 (m, 5H), 6.00–5.85 (m, 1H), 5.43–5.30 (m, 2H), 5.17 (dt,
J = 10.5, 1.5 Hz, 1H), 4.70–4.63 (m, 1H), 3.64 (dd, J = 17.3, 3.0 Hz,
1H), 3.44–3.37 (m, 1H), 3.32–3.20 (m, 2H); 3.04 (dd, J = 13.5,
10.5 Hz, 1H), 2.90 (d, J = 11.3 Hz, 1H), 2.80–2.65 (br s, –OH, 1H).
13C NMR (75 MHz, CDCl3): d 201.0, 172.0, 138.7, 136.1, 129.1,
128.6, 126.9, 114.9, 68.3, 68.0, 60.1, 45.2, 36.5, 31.9; MASS (ESIMS)
m/z 330 (M+Na)+.
(SiO2, 1:9 EtOAc in hexane). ½a D30
ꢂ
¼ ꢀ7:3 (c 0.5, MeOH); lit.8b
½
a 2D9
ꢂ
¼ ꢀ6:1 (c 0.33, MeOH); IR (KBr): 3449, 2926, 2856, 1737,
1253 cmꢀ1 1H NMR (300 MHz; CDCl3): d 5.93–5.69 (m, 2H),
;
4.1.9. (S)-1-[(R)-4-Benzyl-2-thioxothiazolidin-3-yl]-3-(tert-
butyldimethylsilyloxy)pent-4-en-1-one 10
5.38–5.19 (m,3H), 5.09–4.92 (m, 2H), 4.56 (q, J = 7.1 Hz, 1H), 4.45
(t, J = 6.7 Hz, 1H), 4.20–4.18 (m, 1H), 2.59–2.48 (m, 2H), 1.68–
1.52 (m, 4H), 1.49 (s, 3H), 1.39 (s, 3H), 1.39–1.19 (m, 10H), 0.92–
0.81 (m, 12H), 0.10 (s, 3H), 0.08 (s, 3H); 13C NMR (75 MHz, CDCl3)
d 170.5, 140.3, 134.1, 118.4, 114.6, 108.3, 79.5, 74.9, 72.2, 70.6,
43.7, 35.2, 34.8, 31.8, 29.7, 29.4, 29.1, 28.2, 25.8, 25.7, 25.0, 22.6,
18.1, 14.0, ꢀ4.5, ꢀ4.9; (ESI-MS): m/z 505 (M+Na+); HRMS: calcd
for C27H50NaO5Si: 505.3320 (M+Na), found: 505.3322.
To a stirred solution of compound 16 (0.70 g, 2.28 mmol) in dry
DMF (10 mL) at 0 °C under a nitrogen atmosphere were added 2,6-
lutidine (0.42 mL, 3.64 mmol) and TBSCl (0.546 g, 3.64 mmol)
sequentially and stirred at room temperature for 3 h. The reaction
mixture was then quenched with saturated NaHCO3 (5 mL). The or-
ganic layer was separated and the aqueous layer was extracted
with EtOAc (3 ꢁ 20 mL). The combined organic extracts were
washed with water (2 ꢁ 20 mL), brine (1 ꢁ 20 mL) and dried over
anhydrous Na2SO4, filtered and concentrated. The residue was
purified by column chromatography on silica gel (5% EtOAc in hex-
ane) to afford compound 10 (0.883 g, 92%) as a yellow oil. Rf = 0.65
4.1.12. (S)-{(R)-1-[(4S,5R)-2,2-Dimethyl-5-vinyl-1,3-dioxolan-4-
yl]nonan-2-yl} 3-hydroxypent-4-enoate 7
To a stirred solution of compound 17 (400 mg, 0.83 mmol) in
THF (8 mL) at 0 °C, TBAF (1.24 mL, 1.24 mmol, 1 M solution in
THF) was added dropwise at the same temperature. The mixture
was allowed to stir at room temperature for 4 h. The resultant mix-
ture was quenched with water (7 mL) and diluted with diethyl
ether (10 mL). The organic layer was washed with water and then
with brine. The combined organic layers were dried over anhy-
drous Na2SO4, and concentrated under reduced pressure. The resi-
due was purified by chromatography on silica gel (15% EtOAc/
hexane) to give compound 7 (260 mg, 85%) as a yellow liquid.
10% EtOAc in hexane). ½a D25
¼ þ177:5 (c 1.5, CHCl3). IR (Neat): mmax
ꢂ
2931, 2855, 1696, 1645, 1516, 1341, 1252, 1165, 1037, 834 cmꢀ1
.
1H NMR (300 MHz, CDCl3): d 7.40–7.25 (m, 5H, Ar-H), 5.96–5.83
(m, 1H), 5.30–5.20 (m, 2H), 5.09 (d, J = 10.3 Hz, 1H), 4.81–4.74
(m, 1H), 3.69 (dd, J = 16.4, 8.4 Hz, 1H), 3.39–2.27 (m, 2H), 3.21–
2.99 (m, 2H), 2.89 (d, J = 11.5 Hz, 1H), 0.87 (s, 9H), 0.08 (s, 3H),
0.06 (s, 3H). 13C NMR (75 MHz, CDCl3): d 200.9, 171.4, 140.3,
136.5, 129.3, 128.8, 127.1, 114.6, 70.7, 68.6, 46.5, 36.5, 32.1, 25.7,
18.0, ꢀ4.97, ꢀ4.2.;MASS (ESIMS): m/z 444 (M+Na)+.
Rf = 0.4 (SiO2, 2:8 EtOAc in hexane). ½a D28
¼ ꢀ17:2 (c 0.7, CHCl3);
ꢂ
IR (KBr): 3448, 2925, 2858, 1732, 1639, 1376.1
4.1.10. (S)-3-(tert-Butyldimethylsilyloxy)pent-4-enoic acid 2
To a stirred solution of compound 10 (800 mg, 1.90 mmol), H2O
(0.1 mL, 5.70 mmol) and DCM (10 mL) was added DMAP (116 mg,
0.95 mmol) and stirred at rt for 14 h until TLC showed complete
conversion of starting material. The reaction mixture was then di-
luted with ether (20 mL), washed with 1 M HCl (7 mL), water
(7 mL) and brine (5 mL), and dried over anhydrous Na2SO4. After
removal of the solvents, the crude residue was chromatographed
on silica gel (50% EtOAc/hexane) to afford compound 8 (336 mg,
H NMR (300 MHz; CDCl3): d 5.92–5.67 (m, 2H), 5.39–5.09
(m,4H), 5.09–5.00 (m, 1H), 4.55–4.43 (m, 2H), 4.15 (ddd J = 9.1,
6.0, 3.0 Hz, 1H), 2.50(dd, J = 3.8, 1H), 2.47 (dd, J = 8.3 Hz, 1H),
1.70–1.47 (m, 3H), 1.45 (s, 3H), 1.35–1.22 (m, 14H), 0.90 (t,
J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) d 171.8, 138.8, 134.0,
118.5, 115.3, 108.4, 79.4, 74.4, 72.5, 68.9, 41.4, 34.9, 34.6, 31.7,
29.3, 29.1, 28.2, 25.5, 25.1, 22.6, 14.0; (ESI-MS): m/z 391
(M+Na+); HRMS: calcd for C21H36NaO5 391.2455, found: 391.2466.
77%); Rf = 0.2 (SiO2, 6:4 EtOAc in hexane). ½a D28
¼ ꢀ5:2 (c 0.7,
ꢂ
MeOH); lit8b
½
a 2D9
ꢂ
¼ ꢀ4:95 (c 2.0, MeOH); IR (KBr): 3449, 2926,
4.1.13. (3aS,5R,9S,11aR,E)-5-Heptyl-9-hydroxy-2,2-dimethyl-
4,5,8,9-tetrahydro-3aH-[1,3]dioxolo[4,5-d]oxecin-7(11aH)-one
18
2855, 1713, 1464, 1110 cmꢀ1 1H NMR (300 MHz; CDCl3): d 6.16
;
(br s, 1H), 5.84 (ddd, J = 16.6, 10.6, 4.0 Hz, 1H), 5.24 (td, J = 17.4,
1.5 Hz, 1H), 5.07 (td, J = 11.3, 1.5 Hz, 1H), 4.61–4.52 (m, 1H),
2.57–2.38 (m, 2H), 0.88 (s, 9H), 0.06, 0.05 (2s, 6H); 13C NMR
(75 MHz, CDCl3) d 176.3, 139.5, 115.2, 70.6, 43.2, 25.7, 18.1, ꢀ4.4,
ꢀ5.2; (ESI-MS): m/z 231(M+H+).
Ester 7 (90 mg, 0.24 mmol) was dissolved in freshly distilled de-
gassed anhydrous DCM (110 mL) and then treated with Grubbs
catalyst 2nd generation (21 mg, 0.024 mmol) and heated at reflux
for 6 h under an inert atmosphere. The reaction mixture was evap-
orated under reduced pressure to give a brown residue, which was
purified by silica gel column chromatography (20% EtOAc/hexane)
to afford compound 18 (51 mg, 61%) as a light brown liquid;
4.1.11. (S)-{(R)-1-[(4S,5R)-2,2-Dimethyl-5-vinyl-1,3-dioxolan-4-
yl]nonan-2-yl) 3-(tert-butyldimethylsilyloxy)pent-4-enoate 17
From compounds 8 and 9.
Rf = 0.3 (SiO2, 2:8 EtOAc in hexane). ½a D29
ꢂ
¼ ꢀ31 (c 0.8, CHCl3);
lit.7
½
a 2D4
ꢂ
¼ ꢀ33 (c 0.34, CHCl3); IR (neat)
v
max = 3459, 2928, 2858,
To a solution of 9 (250 mg, 0.925 mmol), 8 (234 mg, 1.02 mmol)
and PPh3 (364 mg, 1.4 mmol) in THF (10 mL) at 0 °C was added
DEAD (0.22 mL, 1.40 mmol). Stirring was continued at 0 °C for
1 h and then at rt for 10 h, after which the solution was concen-
trated and the crude residue was purified on silica gel by column
chromatography using (5% ethylacetate in hexane) to obtain 17
(348 mg, 78%) as a colourless oil. Rf = 0.4 (SiO2, 1:9 EtOAc in
hexane).
1728, 1374, 1054, 771 cmꢀ1 1H NMR (300 MHz; CDCl3): d 5.57
;
(dd, J = 8.8, 16.1 Hz, 1H), 5.43 (dd, J = 7.8, 16.1 Hz, 1H), 4.64 (ddd,
J = 5.7, 9.0, 14.3 Hz, 1H), 4.39 (dd, J = 6.3, 9.0 Hz, 1H), 4.27 (q,
J = 7.9 Hz, 1H), 3.91 (dd, J = 6.0, 10.3 Hz, 1H), 2.67 (dd, J = 7.8,
13.3 Hz, 1H), 2.17 (dd, J = 7.9, 13.4 Hz, 1H), 2.10 (dd, J = 5.8,
10.1 Hz, 1H), 1.48 (m, 1H), 1.44 (d, J = 15.8 Hz, 1H), 1.34 (s, 4H),
1.19 (s, 3H), 1.16–1.08 (m, 10H), 0.79 (t, J = 7.0 Hz, 3H); 13C NMR
(75 MHz; CDCl3): d 170.0, 133.5, 129.6, 108.6, 80.8, 77.3, 74.9,
70.0, 43.8, 38.0, 35.7, 31.7, 29.3, 29.1, 28.0, 25.5, 25.3, 22.6, 14.0;
(ESI-MS): m/z 341 (M+H)+; HRMS m/z calcd for C19H32O5Na
363.2142 (M+Na)+ found 363.2137.
From compounds 8 and 9a.
A solution of acid 8 (234 mg, 1.02 mmol) in 8 mL of dichloro-
methane was cooled to 0 °C. A sample of DCC (286 mg, 1.4 mmol)
was added in several portions and a white precipitate formed